Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins.

作者: Stephan T. Kudlacek , Lakshmanane Premkumar , Stefan W. Metz , Ashutosh Tripathy , Andrey A. Bobkov

DOI: 10.1074/JBC.RA118.002658

关键词:

摘要: The spread of dengue (DENV) and Zika virus (ZIKV) is a major public health concern. primary target antibodies that neutralize DENV ZIKV the envelope (E) glycoprotein, there interest in using soluble recombinant E (sRecE) proteins as subunit vaccines. However, most potent neutralizing against recognize epitopes on virion surface span two or more proteins. Therefore, to create effective vaccines, presentation these quaternary may be necessary. sRecE from crystallize native-like dimers, but studies solution suggest dimers are marginally stable. To better understand challenges associated with creating stable we characterized thermostability three serotypes, DENV2-4. All four irreversibly unfolded at moderate temperatures (46-53 °C). At 23 °C low micromolar concentrations, DENV2 were primarily dimeric, DENV3-4 monomeric, whereas 37 °C, all predominantly monomeric. We further show dissociation constant for dimerization very temperature-sensitive, ranging <1 μm 25 50 41 due large exothermic enthalpy binding -79 kcal/mol. also found epitope antibody DENV2-4 reduced °C. Our observation physiological temperature highlights need stabilizing dimer part its development vaccine.

参考文章(54)
Brian Kuhlman, Judith A. Boice, Robert Fairman, Daniel P. Raleigh, Structure and stability of the N-terminal domain of the ribosomal protein L9: evidence for rapid two-state folding. Biochemistry. ,vol. 37, pp. 1025- 1032 ,(1998) , 10.1021/BI972352X
Changhui Yan, Feihong Wu, Robert L. Jernigan, Drena Dobbs, Vasant Honavar, Characterization of Protein–Protein Interfaces Protein Journal. ,vol. 27, pp. 59- 70 ,(2008) , 10.1007/S10930-007-9108-X
Beth-Ann G. Coller, David E. Clements, Andrew J. Bett, Sangeetha L. Sagar, Jan H. Ter Meulen, The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease. Vaccine. ,vol. 29, pp. 7267- 7275 ,(2011) , 10.1016/J.VACCINE.2011.07.021
Yorgo Modis, Steven Ogata, David Clements, Stephen C. Harrison, Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein Journal of Virology. ,vol. 79, pp. 1223- 1231 ,(2005) , 10.1128/JVI.79.2.1223-1231.2005
Ying Zhang, Wei Zhang, Steven Ogata, David Clements, James H Strauss, Timothy S Baker, Richard J Kuhn, Michael G Rossmann, None, Conformational changes of the flavivirus E glycoprotein. Structure. ,vol. 12, pp. 1607- 1618 ,(2004) , 10.1016/J.STR.2004.06.019
Guntur Fibriansah, Joanne L. Tan, Scott A. Smith, Ruklanthi de Alwis, Thiam-Seng Ng, Victor A. Kostyuchenko, Ramesh S. Jadi, Petra Kukkaro, Aravinda M. de Silva, James E. Crowe, Shee-Mei Lok, A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins Nature Communications. ,vol. 6, pp. 6341- 6341 ,(2015) , 10.1038/NCOMMS7341
Leonid V Chernomordik, Ching-Juh Lai, Felix A Rey, Joseph JB Cockburn, M Erika Navarro Sanchez, Ana P Goncalvez, Elena Zaitseva, Enrico A Stura, Carlos M Kikuti, Stéphane Duquerroy, Philippe Dussart, Structural Insights Into the Neutralization Mechanism of a Higher Primate Antibody Against Dengue Virus The EMBO Journal. ,vol. 31, pp. 767- 779 ,(2012) , 10.1038/EMBOJ.2011.439
Yorgo Modis, Steven Ogata, David Clements, Stephen C. Harrison, Structure of the dengue virus envelope protein after membrane fusion Nature. ,vol. 427, pp. 313- 319 ,(2004) , 10.1038/NATURE02165
Jane P Messina, Oliver J Brady, David M Pigott, John S Brownstein, Anne G Hoen, Simon I Hay, None, The global distribution and burden of dengue Nature. ,vol. 496, pp. 504- 507 ,(2013) , 10.1038/NATURE12060